Trong Kim Le

2.7k total citations · 1 hit paper
43 papers, 2.0k citations indexed

About

Trong Kim Le is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Trong Kim Le has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Pharmacology. Recurrent topics in Trong Kim Le's work include Cancer Immunotherapy and Biomarkers (7 papers), Pain Mechanisms and Treatments (6 papers) and Musculoskeletal pain and rehabilitation (5 papers). Trong Kim Le is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Pain Mechanisms and Treatments (6 papers) and Musculoskeletal pain and rehabilitation (5 papers). Trong Kim Le collaborates with scholars based in United States, United Kingdom and France. Trong Kim Le's co-authors include Robert H. Dworkin, Joseph A. Johnston, Xiaolei Zhou, Catherine B. Johannes, John L. Mershon, Russel Burge, Deirdre Mladsi, Amy S. Chappell, R.L. Robinson and Amy Barrett and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Trong Kim Le

41 papers receiving 1.9k citations

Hit Papers

The Prevalence of Chronic... 2010 2026 2015 2020 2010 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Trong Kim Le 813 606 335 291 290 43 2.0k
Nalini Sehgal 827 1.0× 506 0.8× 430 1.3× 107 0.4× 349 1.2× 41 1.8k
Bruce Parsons 631 0.8× 1.2k 2.0× 362 1.1× 142 0.5× 363 1.3× 88 2.5k
Mugdha Gore 1.1k 1.4× 986 1.6× 169 0.5× 102 0.4× 339 1.2× 29 2.2k
Rafael Gálvez 613 0.8× 840 1.4× 241 0.7× 75 0.3× 518 1.8× 67 1.6k
Alaa Abd‐Elsayed 756 0.9× 730 1.2× 823 2.5× 126 0.4× 824 2.8× 289 2.9k
Martin Mücke 530 0.7× 347 0.6× 129 0.4× 144 0.5× 113 0.4× 82 1.7k
Mick Serpell 793 1.0× 626 1.0× 986 2.9× 134 0.5× 399 1.4× 60 2.3k
Hilary Wilson 703 0.9× 430 0.7× 240 0.7× 84 0.3× 259 0.9× 66 1.8k
Sharon Hertz 887 1.1× 388 0.6× 281 0.8× 73 0.3× 418 1.4× 23 2.2k
Burkhard Gustorff 565 0.7× 780 1.3× 634 1.9× 74 0.3× 474 1.6× 90 2.3k

Countries citing papers authored by Trong Kim Le

Since Specialization
Citations

This map shows the geographic impact of Trong Kim Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trong Kim Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trong Kim Le more than expected).

Fields of papers citing papers by Trong Kim Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trong Kim Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trong Kim Le. The network helps show where Trong Kim Le may publish in the future.

Co-authorship network of co-authors of Trong Kim Le

This figure shows the co-authorship network connecting the top 25 collaborators of Trong Kim Le. A scholar is included among the top collaborators of Trong Kim Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trong Kim Le. Trong Kim Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kirkwood, John M., Lisa A. Kottschade, Robert R. McWilliams, et al.. (2023). Real-World Outcomes with Immuno-Oncology Therapies in Advanced Melanoma: Final Results of the OPTIMIzE Registry Study. Immunotherapy. 16(1). 29–42. 3 indexed citations
3.
Le, Trong Kim, et al.. (2023). Neoadjuvant treatment and survival outcomes by pathologic complete response in HER2-negative early breast cancers. Future Oncology. 19(3). 229–244. 1 indexed citations
5.
Geynisman, Daniel M., et al.. (2021). Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States. Urologic Oncology Seminars and Original Investigations. 40(5). 195.e1–195.e11. 28 indexed citations
6.
Stenehjem, David D., Solomon J. Lubinga, Komal Gupte-Singh, et al.. (2020). Real-World Effectiveness of Nivolumab Monotherapy After Prior Systemic Therapy in Advanced Non–Small-Cell Lung Cancer in the United States. Clinical Lung Cancer. 22(1). e35–e47. 5 indexed citations
8.
Kotapati, Srividya, Ying Zhang, Trong Kim Le, & James W. Shaw. (2015). Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma. ClinicoEconomics and Outcomes Research. 7. 397–397. 4 indexed citations
9.
Broglio, Kristine, Melanie Quintana, Eric S. Daar, et al.. (2014). Determining Comparative Effectiveness Benchmarks for Emerging Treatments for Hepatitis C Virus (Hcv) Infection in the Single Arm Study Design Setting. Value in Health. 17(3). A2–A2. 2 indexed citations
10.
Le, Trong Kim, et al.. (2013). Tibia shaft fractures: costly burden of nonunions. BMC Musculoskeletal Disorders. 14(1). 42–42. 273 indexed citations
11.
Classi, Peter, et al.. (2011). Patient characteristics, comorbidities, and medication use for children with ADHD with and without a co-occurring reading disorder: A retrospective cohort study. Child and Adolescent Psychiatry and Mental Health. 5(1). 38–38. 4 indexed citations
12.
Johannes, Catherine B., Trong Kim Le, Xiaolei Zhou, Joseph A. Johnston, & Robert H. Dworkin. (2010). The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based Survey. Journal of Pain. 11(11). 1230–1239. 955 indexed citations breakdown →
13.
Roskell, Neil, S Beard, Yang Zhao, & Trong Kim Le. (2010). A Meta‐Analysis of Pain Response in the Treatment of Fibromyalgia. Pain Practice. 11(6). 516–527. 35 indexed citations
14.
Zhao, Yang, Wenyu Ye, Trong Kim Le, et al.. (2009). Comparing clinical and economic characteristics between commercially-insured patients with diabetic neuropathy and demographically-matched diabetic controls. Current Medical Research and Opinion. 25(3). 585–597. 8 indexed citations
15.
Le, Trong Kim, et al.. (2009). The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opinion on Pharmacotherapy. 10(16). 2581–2592. 176 indexed citations
16.
Quilici, Sibilia, J Chancellor, Mickael Löthgren, et al.. (2009). Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurology. 9(1). 6–6. 155 indexed citations
17.
Barrett, Amy, et al.. (2007). Epidemiology, Public Health Burden, and Treatment of Diabetic Peripheral Neuropathic Pain: A Review. Pain Medicine. 8(suppl 2). S50–S62. 179 indexed citations
18.
Armstrong, David G., Amy S. Chappell, Trong Kim Le, et al.. (2007). Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evaluation of Functional Outcomes. Pain Medicine. 8(5). 410–418. 27 indexed citations
19.
Wernicke, Joachim, Joel Raskin, A. Rosen, et al.. (2006). Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial. Current Therapeutic Research. 67(5). 283–304. 21 indexed citations
20.
Le, Trong Kim, Stephen L. Able, & Maureen J. Lage. (2006). Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Effectiveness and Resource Allocation. 4(1). 18–18. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026